Clinical Benefits
-
-
-
Increased bone-to-implant contact (BIC)
-
Complete implant surface wettability and coverage
-
Greater initial protein attachment and osteoblast proliferation than with SLA/SLA+UV
-
Faster healing and osseointegration – with an increase in bone volume
-
Helps improve success rates through enhanced osteogenic potential in compromised bone cases
-
Does not alter surface morphology/chemistry or impair SLA+AE results
-
Enhanced production of osteoblast differentiation markers – more than in implants that have been grit-blasted or acid-etched alone
-
Increased paracrine signaling factors, including BMP2 and VEGF-A
-
-